1、Zhu S, Lee DA, Li S.. IL12 and IL27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.. J Immunol.,2010;184(5):2348-54
2、Craig R, Cutrera J, Zhu S, Xia X, Lee YH, Li S.. Administering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within or into tumors.. Mol Ther.,2008;16(5):901-906
3、Zhu S, Li S. . Systemic IL12 gene therapy for treating malignancy via intramuscular electroporation.. Methods Mol Biol.,2008;423:327-37
4、Zhu S, Waguespack M, Barker SA, Li S.. Doxorubicin Enhances Accumulation of Systemic IL-12 Gene Therapy-Induced IFNγ into Tumors and Induces IFNγ Signaling-Dependent Therapeutic Effect.. Clin Cancer Res.,2007;13 (14):4252-60
5、Li Z, Zhu S, Gan K, Zhang Q, Zeng Z, Zhou Y, Liu H, Xiong W, Li X, Li G. . Poly-L-lysine-modified silica nanoparticles: a potential oral gene delivery system. . J Nanosci Nanotechnol.,2005;5(8):1199-203
6、Zhu SG, Xiang JJ, Li XL, Shen SR, Lu HB, Zhou J, Xiong W, Zhang BC, Nie XM, Zhou M, Tang K, Li GY. Poly(L-lysine)-modified silica nanoparticles for the delivery of antisense oligonucleotides.. Biotechnol Appl Biochem.,2004;39(Pt 2):179-87
7、Zhu SG, Lu HB, Xiang JJ, Tang K, Zhang BC, Zhou M, Tan C, Li GY. . A novel nonviral nanoparticle gene vector: poly-L-lysine silica nanoparticles. Chin Sci Bull,2002;47(8):654-657.
|
